CD8A and neoplasm: LLC tumor growth was halted by treatment with CT plus anti-PD-L1; however, simultaneous administration of anti-CD8 antibody completely abolished the therapeutic effect of CT plus anti-PD-L1 (Fig. 6c), demonstrating the critical contribution of CD8 T cells to the antitumor effect of CT.